.. Encapsulation-of-salmon-calcitonin, 26 2.2.1. Physiologic action and clinical use of calcitonin 29 2.2.3. Pharmaceutical preparations, side effects and pharmacokinetics Parenteral sustained release calcitonin delivery systems, 26 2.2.2. Structural properties and stability, p.46

.. Encapsulation-of-salmon-calcitonin, 63 4.2.2.1. Preparation of salmon calcitonin-loaded nanoparticles Study on salmon calcitonin adsorption to blank nanoparticles, p.73

T. Akamatsu, M. Minemoto, and M. Uyeda, Evaluation of the Antimicrobial Activity and Materials Compatibility of Orthophthalaldehyde as a High-level Disinfectant, Journal of International Medical Research, vol.33, issue.2, pp.178-187, 2005.
DOI : 10.1016/0195-6701(94)90075-2

E. Allemann, J. Leroux, and R. Gurny, Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics, Advanced Drug Delivery Reviews, vol.34, issue.2-3, pp.171-189, 1998.
DOI : 10.1016/S0169-409X(98)00039-8

P. Amodeo, A. Motta, G. Strazzullo, and M. Morelli, Conformational flexibility in calcitonin: the dynamic properties of human and salmon calcitonin in solution, Journal of Biomolecular NMR, vol.13, issue.2, pp.161-174, 1999.
DOI : 10.1023/A:1008365322148

K. Antonin, V. Saano, P. Bieck, J. Hastewell, R. Fox et al., Colonic absorption of human calcitonin in man, Clinical Science, vol.83, issue.5, pp.627-631, 1992.
DOI : 10.1042/cs0830627

T. Arvinte and A. Drake, Comparative study of human and salmon calcitonin secondary structure in solutions with low dielectric constants, J Biol Chem, vol.268, pp.6408-6414, 1993.

T. Arvinte, A. Cudd, and A. Drake, The structure and mechanism of formation of human calcitonin fibrils, J Biol Chem, vol.268, pp.6415-6422, 1993.

M. Azria, D. Copp, and J. Zanelli, 25 Years of salmon calcitonin: From synthesis to therapeutic use, Calcified Tissue International, vol.19, issue.suppl 2, pp.405-408, 1995.
DOI : 10.1111/j.1445-5994.1979.tb04110.x

Y. Bagger, L. Tanko, and P. Alexandersen, Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: A new potential treatment of osteoarthritis, Bone, vol.37, issue.3, pp.425-430, 2005.
DOI : 10.1016/j.bone.2005.04.032

R. Barhoumi, R. Bailey, and R. Burghardt, Kinetic analysis of glutathione in anchored cells with monochlorobimane, Cytometry, vol.96, issue.3, pp.226-234, 1995.
DOI : 10.1128/MCB.7.3.1280

G. Barratt, Colloidal drug carriers: achievements and perspectives, Cellular and Molecular Life Sciences (CMLS), vol.60, issue.1, pp.21-37, 2003.
DOI : 10.1007/s000180300002

H. Basan, M. Gumusderelioglu, and M. Orbey, Release characteristics of salmon calcitonin from dextran hydrogels for colon-specific delivery, European Journal of Pharmaceutics and Biopharmaceutics, vol.65, issue.1, pp.39-46, 2007.
DOI : 10.1016/j.ejpb.2006.07.008

M. Baudys, D. Mix, and S. Kim, Stabilization and intestinal absorption of human calcitonin, Journal of Controlled Release, vol.39, issue.2-3, pp.145-151, 1996.
DOI : 10.1016/0168-3659(95)00148-4

G. Bellomo, G. Palladini, and M. Vairetti, Intranuclear distribution, function and fate of glutathione and glutathione-S-conjugate in living rat hepatocytes studied by fluorescence microscopy, Microscopy Research and Technique, vol.I, issue.4, pp.243-252, 1997.
DOI : 10.1016/B978-0-12-380001-5.50022-0

A. Bernkop-schnurch, Chitosan and its derivatives: potential excipients for peroral peptide delivery systems, International Journal of Pharmaceutics, vol.194, issue.1, pp.1-13, 2000.
DOI : 10.1016/S0378-5173(99)00365-8

A. Bernkop-schnurch, C. Kast, and D. Guggi, Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems, Journal of Controlled Release, vol.93, issue.2, pp.95-103, 2003.
DOI : 10.1016/j.jconrel.2003.05.001

T. Beveridge, W. Niederer, E. Nuesch, and A. Petrin, Pharmacokinetic study with synthetic salmon calcitonin (Sandoz), Z Gastroenterol Verh, vol.10, pp.12-15, 1976.

U. Bilati, E. Allemann, and E. Doelker, Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles, European Journal of Pharmaceutics and Biopharmaceutics, vol.59, issue.3, pp.375-388, 2005.
DOI : 10.1016/j.ejpb.2004.10.006

M. Blanco and M. Alonso, Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres, European Journal of Pharmaceutics and Biopharmaceutics, vol.43, issue.3, pp.287-294, 1997.
DOI : 10.1016/S0939-6411(97)00056-8

R. Bodmeier, H. Plieberman, M. Rieger, and G. Banker, Polymeric Dispersions as Drug Carriers Pharmaceutical Dosage Forms: Disperse Systems Informa Health Care, pp.87-127, 1998.

J. Body, Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis, Bone, vol.30, issue.5, pp.75-79, 2002.
DOI : 10.1016/S8756-3282(02)00715-9

T. Buclin, M. Rochat, P. Burckhardt, M. Azria, and M. Attinger, Bioavailability and Biological Efficacy of a New Oral Formulation of Salmon Calcitonin in Healthy Volunteers, Journal of Bone and Mineral Research, vol.285, issue.8, pp.1478-1485, 2002.
DOI : 10.1007/BF02508638

J. Cai, Y. Chen, S. Seth, S. Furukawa, R. Compans et al., Inhibition of influenza infection by glutathione, Free Radical Biology and Medicine, vol.34, issue.7, pp.928-936, 2003.
DOI : 10.1016/S0891-5849(03)00023-6

E. Camera and M. Picardo, Analytical methods to investigate glutathione and related compounds in biological and pathological processes, Journal of Chromatography B, vol.781, issue.1-2, pp.181-206, 2002.
DOI : 10.1016/S1570-0232(02)00618-9

M. Capelle, R. Gurny, and T. Arvinte, High throughput screening of protein formulation stability: Practical considerations, European Journal of Pharmaceutics and Biopharmaceutics, vol.65, issue.2, pp.131-148, 2007.
DOI : 10.1016/j.ejpb.2006.09.009

M. Capelle, R. Gurny, and T. Arvinte, A High Throughput Protein Formulation Platform: Case Study of Salmon Calcitonin, Pharmaceutical Research, vol.38, issue.1, pp.118-128, 2009.
DOI : 10.1615/CritRevNeurobiol.v11.i2-3.40

S. Caruthers, S. Wickline, and G. Lanza, Nanotechnological applications in medicine, Current Opinion in Biotechnology, vol.18, issue.1, pp.26-30, 2007.
DOI : 10.1016/j.copbio.2007.01.006

C. Cereser, J. Guichard, and J. Drai, Quantitation of reduced and total glutathione at the femtomole level by high-performance liquid chromatography with fluorescence detection: application to red blood cells and cultured fibroblasts, Journal of Chromatography B: Biomedical Sciences and Applications, vol.752, issue.1, pp.123-132, 2001.
DOI : 10.1016/S0378-4347(00)00534-X

A. Chaturvedula, D. Joshi, C. Anderson, R. Morris, W. Sembrowich et al., In vivo iontophoretic delivery and pharmacokinetics of salmon calcitonin, International Journal of Pharmaceutics, vol.297, pp.190-196, 2005.
DOI : 10.1016/j.ijpharm.2005.03.019

Y. Chernysheva, V. Babak, N. Kildeeva, F. Boury, J. Benoit et al., Effect of the type of hydrophobic polymers on the size of nanoparticles obtained by emulsification???solvent evaporation, Mendeleev Communications, vol.13, issue.2, pp.65-68, 2003.
DOI : 10.1070/MC2003v013n02ABEH001690

I. Chesnut, . Ch, M. Azria, S. Silverman, M. Engelhardt et al., Salmon calcitonin: a review of current and future therapeutic indications, Osteoporosis International, vol.350, issue.11, pp.479-491, 2008.
DOI : 10.1002/jbmr.5650140211

I. Chesnut, . Ch, S. Silverman, and K. Andriano, A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study, The American Journal of Medicine, vol.109, issue.4, pp.267-276, 2000.
DOI : 10.1016/S0002-9343(00)00490-3

M. Cholewinski, B. Luckel, and H. Horn, Degradation pathways, analytical characterization and formulation strategies of a peptide and a protein calcitonine and human growth hormone in comparison, Pharmaceutica Acta Helvetiae, vol.71, issue.6, pp.405-419, 1996.
DOI : 10.1016/S0031-6865(96)00049-0

S. Clarke, C. Hollmann, and Z. Zhang, Photophysics of dopamine-modified quantum dots and effects on biological systems, Nature Materials, vol.123, issue.112, pp.409-417, 2006.
DOI : 10.1021/ja016424q

A. Clausen, C. Kast, and A. Bernkop-schnurch, The role of glutathione in the permeation enhancing effect of thiolated polymers, Pharmaceutical Research, vol.19, issue.5, pp.602-608, 2002.
DOI : 10.1023/A:1015345827091

B. Combe, C. Cohen, and F. Aubin, Equivalence of Nasal Spray and Subcutaneous Formulations of Salmon Calcitonin, Calcified Tissue International, vol.61, issue.1, pp.10-15, 1997.
DOI : 10.1007/s002239900284

D. Copp, A. Davidson, and B. Cheney, Evidence for a new parathyroid hormone which lowers blood calcium, Proc Can Fed Biol Soc, vol.4, p.17, 1961.

P. Couvreur, G. Barratt, E. Fattal, P. Legrand, and C. Vauthier, Nanocapsule Technology: A Review, Critical Reviews in Therapeutic Drug Carrier Systems, vol.19, issue.2, pp.99-134, 2002.
DOI : 10.1615/CritRevTherDrugCarrierSyst.v19.i2.10

C. Damge, P. Maincent, and N. Ubrich, Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats, Journal of Controlled Release, vol.117, issue.2, pp.163-170, 2007.
DOI : 10.1016/j.jconrel.2006.10.023

B. Dani and P. Deluca, Preparation, characterization, and in vivo evaluation of salmon calcitonin microspheres, AAPS PharmSciTech, vol.2, issue.4, p.22, 2001.
DOI : 10.1208/pt020422

O. Deas, C. Dumont, and B. Mollereau, Thiol-mediated inhibition of FAS and CD2 apoptotic signaling in activated human peripheral T cells, International Immunology, vol.9, issue.1, pp.117-125, 1997.
DOI : 10.1093/intimm/9.1.117

F. Delie and M. Blanco-prieto, Polymeric Particulates to Improve Oral Bioavailability of Peptide Drugs, Molecules, vol.13, issue.1, pp.65-80, 2005.
DOI : 10.3109/02652049609026049

C. Demerlis and D. Schoneker, Review of the oral toxicity of polyvinyl alcohol (PVA), Food and Chemical Toxicology, vol.41, issue.3, pp.319-326, 2003.
DOI : 10.1016/S0278-6915(02)00258-2

H. Devalapally, A. Chakilam, and M. Amiji, Role of Nanotechnology in Pharmaceutical Product Development, Journal of Pharmaceutical Sciences, vol.96, issue.10, pp.2547-2565, 2007.
DOI : 10.1002/jps.20875

R. Diaz, M. Llabres, and C. Evora, One-month sustained release microspheres of 125I-bovine calcitonin, Journal of Controlled Release, vol.59, issue.1, pp.55-62, 1999.
DOI : 10.1016/S0168-3659(98)00179-5

D. Dickinson and H. Forman, Cellular glutathione and thiols metabolism, Biochemical Pharmacology, vol.64, issue.5-6, pp.1019-1026, 2002.
DOI : 10.1016/S0006-2952(02)01172-3

L. Diez, E. Martenka, A. Dabrowska, J. Coulon, and P. Leroy, Assessment of in situ cellular glutathione labeling with naphthalene-2,3-dicarboxaldehyde using high-performance liquid chromatography, Journal of Chromatography B, vol.827, issue.1, pp.44-50, 2005.
DOI : 10.1016/j.jchromb.2005.02.007

R. Dijkhuizen-radersma, H. Nicolas, M. Weert, M. Blom, K. Groot et al., Stability aspects of salmon calcitonin entrapped in poly(ether-ester) sustained release systems, International Journal of Pharmaceutics, vol.248, issue.1-2, pp.229-237, 2002.
DOI : 10.1016/S0378-5173(02)00458-1

K. Dillen, J. Vandervoort, G. Van-den-mooter, and A. Ludwiga, Evaluation of ciprofloxacin-loaded Eudragit?? RS100 or RL100/PLGA nanoparticles, International Journal of Pharmaceutics, vol.314, issue.1, pp.72-82, 2006.
DOI : 10.1016/j.ijpharm.2006.01.041

S. Dogru, S. Calis, and F. Oner, Oral multiple w/o/w emulsion formulation of a peptide salmon calcitonin: in vitro-in vivo evaluation, Journal of Clinical Pharmacy and Therapeutics, vol.49, issue.6, pp.435-443, 2000.
DOI : 10.1016/0169-409X(89)90018-5

F. Dorkoosh, J. Verhoef, M. Rafiee-tehrani, G. Borchard, and H. Junginger, Peroral drug delivery systems for peptides and proteins, S.T.P. Pharma Sci, vol.12, pp.213-221, 2002.

M. Dziurla, P. Leroy, and G. Strunkmann, Measurement of glutathione in activated sludges, Water Research, vol.38, issue.1, pp.236-244, 2004.
DOI : 10.1016/j.watres.2003.08.028

B. Ettinger, D. Black, and B. Mitlak, Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene: Results From a 3-Year Randomized Clinical Trial, Obstetrical & Gynecological Survey, vol.55, issue.1, pp.637-645, 1999.
DOI : 10.1097/00006254-200001000-00021

N. Faisant, J. Akiki, F. Siepmann, J. Benoit, and J. Siepmann, Effects of the type of release medium on drug release from PLGA-based microparticles: Experiment and theory, International Journal of Pharmaceutics, vol.314, issue.2, pp.189-197, 2006.
DOI : 10.1016/j.ijpharm.2005.07.030

R. Franco, O. Schoneveld, A. Pappa, and M. Panayiotidis, The central role of glutathione in the pathophysiology of human diseases, Archives of Physiology and Biochemistry, vol.134, issue.4-5, pp.234-258, 2007.
DOI : 10.1182/blood-2003-12-4299

W. Friess and M. Schlapp, Release mechanisms from gentamicin loaded poly(lactic-co-glycolic acid) (PLGA) microparticles, Journal of Pharmaceutical Sciences, vol.91, issue.3, pp.845-856, 2002.
DOI : 10.1002/jps.10012

K. Fu, A. Klibanov, and R. Langer, Protein stability in controlled-release systems, Nature Biotechnology, vol.92, issue.1, 2000.
DOI : 10.1073/pnas.92.24.10969

P. Gao, P. Ding, H. Xu, Z. Yuan, D. Chen et al., In Vitro and in Vivo Characterization of Huperzine A Loaded Microspheres Made from End-Group Uncapped Poly(d,l-lactide acid) and Poly(d,l-lactide-co-glycolide acid), CHEMICAL & PHARMACEUTICAL BULLETIN, vol.54, issue.1, pp.89-93, 2006.
DOI : 10.1248/cpb.54.89

X. Gao, L. Yang, J. Petros, F. Marshall, J. Simons et al., In vivo molecular and cellular imaging with quantum dots, Current Opinion in Biotechnology, vol.16, issue.1, pp.63-72, 2005.
DOI : 10.1016/j.copbio.2004.11.003

M. Garcia-fuentes, C. Prego, D. Torres, and M. Alonso, A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery, European Journal of Pharmaceutical Sciences, vol.25, issue.1, pp.133-143, 2005.
DOI : 10.1016/j.ejps.2005.02.008

L. Gate, C. Vauthier, P. Couvreur, K. Tew, and H. Tapiero, Glutathione-loaded poly(isobutylcyanoacrylate) nanoparticles and liposomes: comparative effects in murine erythroleukemia and macrophage-like cells S, T.P. Pharma Sci, vol.11, pp.355-361, 2001.

M. Gaudiano, M. Colone, C. Bombelli, P. Chistolini, L. Valvo et al., Early stages of salmon calcitonin aggregation: Effect induced by ageing and oxidation processes in water and in the presence of model membranes, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, vol.1750, issue.2, pp.134-145, 2005.
DOI : 10.1016/j.bbapap.2005.04.008

C. Gennari, Analgesic effect of calcitonin in osteoporosis, Bone, vol.30, issue.5, pp.67-70, 2002.
DOI : 10.1016/S8756-3282(02)00713-5

E. G?ówka, A. Lamprecht, N. Ubrich, P. Maincent, J. Lulek et al., Enhanced cellular uptake of a glutathione selective fluorogenic probe encapsulated in nanoparticles, Nanotechnology, vol.17, issue.10, pp.2546-2552, 2006.
DOI : 10.1088/0957-4484/17/10/018

M. Goldberg and I. Gomez-orellana, Challenges for the oral delivery of macromolecules, Nature Reviews Drug Discovery, vol.64, issue.4, pp.289-295, 2003.
DOI : 10.1016/S0168-3659(99)00144-3

W. Gombotz and D. Pettit, Biodegradable Polymers for Protein and Peptide Drug Delivery, Bioconjugate Chemistry, vol.6, issue.4, pp.332-351, 1995.
DOI : 10.1021/bc00034a002

D. Guggi, A. Krauland, and A. Bernkop-schnurch, Systemic peptide delivery via the stomach: in vivo evaluation of an oral dosage form for salmon calcitonin, Journal of Controlled Release, vol.92, issue.1-2, pp.125-135, 2003.
DOI : 10.1016/S0168-3659(03)00299-2

M. Gutscher, A. Pauleau, and L. Marty, Real-time imaging of the intracellular glutathione redox potential, Nature Methods, vol.45, issue.6, pp.553-559, 2008.
DOI : 10.4049/jimmunol.174.9.5249

W. Haining, D. Anderson, and S. Little, pH-Triggered Microparticles for Peptide Vaccination, The Journal of Immunology, vol.173, issue.4, pp.2578-2585, 2004.
DOI : 10.4049/jimmunol.173.4.2578

C. Hall and O. Hall, Polyvinyl Alcohol Nephrosis: Relationship of Degree of Polymerization to Pathophysiologic Effects., Experimental Biology and Medicine, vol.112, issue.1, pp.86-91, 1963.
DOI : 10.3181/00379727-112-27958

R. Hanczko, A. Jambor, A. Perl, and I. Molnar-perl, Advances in the o-phthalaldehyde derivatizations, Journal of Chromatography A, vol.1163, issue.1-2, pp.25-42, 2007.
DOI : 10.1016/j.chroma.2007.06.013

S. Harris, N. Watts, and H. Genant, Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>, JAMA, vol.282, issue.14, pp.1344-1352, 1999.
DOI : 10.1001/jama.282.14.1344

J. Hastewell, S. Lynch, I. Williamson, R. Fox, and M. Mackay, Enhancement of human calcitonin absorption across the rat colon in vivo, International Journal of Pharmaceutics, vol.101, issue.1-2, pp.589-594, 1992.
DOI : 10.1016/0378-5173(94)90082-5

R. Haugland, The Handbook -A Guide to Fluorescent Probes and Labeling Technologies, Invitrogen Corp, 2005.

C. Hayter, An EPSRC view of the nanotechnology horizon, Materials Science and Engineering: C, vol.23, issue.6-8, pp.703-705, 2003.
DOI : 10.1016/j.msec.2003.09.078

X. He, Z. Zhong, and Y. Guo, Gold Nanoparticle-Based Monitoring of the Reduction of Oxidized to Reduced Glutathione, Langmuir, vol.23, issue.17, pp.8815-8819, 2007.
DOI : 10.1021/la7011028

D. Hedley and S. Chow, Evaluation of methods for measuring cellular glutathione content using flow cytometry, Cytometry, vol.51, issue.4, pp.349-358, 1994.
DOI : 10.1016/0360-3016(86)90169-0

V. Hoffart, N. Ubrich, and C. Simonin, Low Molecular Weight Heparin-Loaded Polymeric Nanoparticles: Formulation, Characterization, and Release Characteristics, Drug Development and Industrial Pharmacy, vol.135, issue.9, pp.1091-1099, 2002.
DOI : 10.1016/S0168-3659(99)00012-7

M. Hombreiro-perez, C. Zinutti, and A. Lamprecht, The preparation and evaluation of poly(??-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug, Journal of Controlled Release, vol.65, issue.3, pp.429-438, 2000.
DOI : 10.1016/S0168-3659(99)00253-9

M. Ikegame, S. Ejiri, and H. Ozawa, Calcitonin-induced change in serum calcium levels and its relationship to osteoclast morphology and number of calcitonin receptors, Bone, vol.35, issue.1, pp.27-33, 2004.
DOI : 10.1016/j.bone.2004.03.018

K. Jain, Nanomedicine: Application of Nanobiotechnology in Medical Practice, Medical Principles and Practice, vol.2, issue.2, 2008.
DOI : 10.1166/jnn.2006.155

G. Jiang, B. Woo, F. Kang, J. Singh, and P. Deluca, Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(?,?-lactide-co-glycolide) microspheres, Journal of Controlled Release, vol.79, issue.1-3, pp.137-145, 2002.
DOI : 10.1016/S0168-3659(01)00533-8

Y. Jiao, N. Ubrich, M. Marchand-arvier, C. Vigneron, M. Hoffman et al., Preparation and In Vitro Evaluation of Heparin-Loaded Polymeric Nanoparticles, Drug Delivery, vol.4, issue.3, pp.135-141, 2001.
DOI : 10.1248/cpb.30.2245

P. Johansen, G. Corradin, H. Merkle, and B. Gander, Release of tetanus toxoid from adjuvants and PLGA microspheres: How experimental set-up and surface adsorption fool the pattern, Journal of Controlled Release, vol.56, issue.1-3, pp.209-217, 1998.
DOI : 10.1016/S0168-3659(98)00084-4

K. Ma, B. Sondergaard, M. Arnold, and C. Christiansen, Calcitonin affects both bone and cartilage. A dual action treatment for osteoarthritis?, Ann NY Acad Sci, vol.1117, pp.181-195, 2007.

M. Karsdal, K. Henriksen, M. Arnold, and C. Christiansen, Calcitonin ??? A Drug of the Past or for the Future?, BioDrugs, vol.2, issue.2, pp.137-144, 2008.
DOI : 10.1016/0306-3623(94)00210-E

K. Kawamura, T. Matsumoto, T. Nakahara, M. Hirano, H. Uchimura et al., IMPROVED METHOD FOR DETERMINATION OF ??-PHENYLETHYLAMINE IN HUMAN PLASMA BY SOLID-PHASE EXTRACTION AND HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY WITH FLUORESCENCE DETECTION, Journal of Liquid Chromatography & Related Technologies, vol.91, issue.13, pp.1981-1993, 2000.
DOI : 10.1016/0003-2697(86)90068-0

Y. Kawashima, H. Yamamoto, H. Takeuchi, and Y. Kuno, Mucoadhesive DL-Lactide/Glycolide Copolymer Nanospheres Coated with Chitosan to Improve Oral Delivery of Elcatonin, Pharmaceutical Development and Technology, vol.13, issue.1, pp.77-85, 2000.
DOI : 10.1016/S0378-5173(96)04861-2

Y. Kawashima, H. Yamamoto, H. Takeuchi, T. Hino, and T. Niwa, Properties of a peptide containing dl-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods, European Journal of Pharmaceutics and Biopharmaceutics, vol.45, issue.1, pp.41-48, 1998.
DOI : 10.1016/S0939-6411(97)00121-5

C. Keck and R. Muller, Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation, European Journal of Pharmaceutics and Biopharmaceutics, vol.62, issue.1, pp.3-16, 2006.
DOI : 10.1016/j.ejpb.2005.05.009

T. Kerppola, Visualization of molecular interactions by fluorescence complementation, Nature Reviews Molecular Cell Biology, vol.58, issue.6, pp.449-456, 2006.
DOI : 10.1111/j.1365-2958.2005.04852.x

P. Kidd, Glutathione: systemic protectant against oxidative and free radical damage, Altern Med Rev, vol.2, pp.155-176, 1997.

M. Kidron, S. Dinh, and Y. Menachem, A novel per-oral insulin formulation: proof of concept study in non-diabetic subjects, Diabetic Medicine, vol.45, issue.4, pp.354-357, 2004.
DOI : 10.1016/S1056-8727(01)00154-4

J. Kretlow, L. Klouda, and A. Mikos, Injectable matrices and scaffolds for drug delivery in tissue engineering, Advanced Drug Delivery Reviews, vol.59, issue.4-5, pp.263-273, 2007.
DOI : 10.1016/j.addr.2007.03.013

V. &. Kulinsky and L. Kolesnichenko, Mitochondrial glutathione, Biochemistry (Moscow), vol.20, issue.7, pp.698-701, 2007.
DOI : 10.1165/ajrcmb.20.2.3367

D. Kutlan, P. Presits, and I. Molnar-perl, Behavior and characteristics of amine derivatives obtained with o-phthaldialdehyde/3-mercaptopropionic acid and with o-phthaldialdehyde/N-acetyl-l-cysteine reagents, Journal of Chromatography A, vol.949, issue.1-2, pp.235-248, 2002.
DOI : 10.1016/S0021-9673(01)01610-7

M. Lai and E. Topp, Solid???state chemical stability of proteins and peptides, Journal of Pharmaceutical Sciences, vol.88, issue.5, pp.489-500, 1999.
DOI : 10.1021/js980374e

S. Lamba, A. Pandit, and S. Sanghi, Determination of aliphatic amines by high-performance liquid chromatography-amperometric detection after derivatization with naphthalene-2,3-dicarboxaldehyde, Analytica Chimica Acta, vol.614, issue.2, pp.190-195, 2008.
DOI : 10.1016/j.aca.2008.03.011

A. Lamprecht, H. Yamamoto, H. Takeuchi, and Y. Kawashima, pH-sensitive microsphere delivery increases oral bioavailability of calcitonin, Journal of Controlled Release, vol.98, issue.1, pp.1-9, 2004.
DOI : 10.1016/j.jconrel.2004.02.001

S. Law and C. Shih, Adsorption of Calcitonin to Glass, Drug Development and Industrial Pharmacy, vol.50, issue.2, pp.253-256, 1999.
DOI : 10.1016/0378-5173(94)00402-Q

K. Lee, Y. Lee, H. Song, C. Chun, and P. Deluca, Degradation of synthetic salmon calcitonin in aqueous solution, Pharmaceutical Research, vol.09, issue.11, pp.1521-1523, 1992.
DOI : 10.1023/A:1015839719618

K. Lee, E. Soltis, P. Newman, K. Buron, R. Mehta et al., In vivo assessment of salmon calcitonin sustained release from biodegradable microspheres, Journal of Controlled Release, vol.17, issue.2, pp.199-206, 1991.
DOI : 10.1016/0168-3659(91)90059-M

K. Lee, K. Tak, and M. Park, Preparation and Characterization of Polyethylene-Glycol-Modified Salmon Calcitonins, Pharmaceutical Development and Technology, vol.694, issue.2, pp.269-275, 1999.
DOI : 10.1016/S0378-4347(97)00154-0

K. Lee, M. Park, and D. Na, Intranasal Delivery of PEGylated Salmon Calcitonins: Hypocalcemic Effects in Rats, Calcified Tissue International, vol.7, issue.8574, pp.545-549, 2003.
DOI : 10.1023/A:1015921101465

Y. Lee and P. Sinko, Oral delivery of salmon calcitonin, Advanced Drug Delivery Reviews, vol.42, issue.3, pp.225-238, 2000.
DOI : 10.1016/S0169-409X(00)00063-6

K. Lenton, H. Therriault, and J. Wagner, Analysis of Glutathione and Glutathione Disulfide in Whole Cells and Mitochondria by Postcolumn Derivatization High-Performance Liquid Chromatography with ortho-Phthalaldehyde, Analytical Biochemistry, vol.274, issue.1, pp.125-130, 1999.
DOI : 10.1006/abio.1999.4258

P. Leroy, A. Nicolas, M. Wellmann, F. Michelet, T. Oster et al., Evaluation ofo-phthalaldehyde as bifunctional fluorogenic post-column reagent for glutathione in LC, Chromatographia, vol.200, issue.1, pp.130-134, 1993.
DOI : 10.1007/BF02263849

K. Letchford and H. Burt, A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes, European Journal of Pharmaceutics and Biopharmaceutics, vol.65, issue.3, pp.259-269, 2007.
DOI : 10.1016/j.ejpb.2006.11.009

K. Lewicki, S. Marchand, L. Matoub, J. Lulek, J. Coulon et al., Development of a fluorescence-based microtiter plate method for the measurement of glutathione in yeast, Talanta, vol.70, issue.4, pp.876-882, 2006.
DOI : 10.1016/j.talanta.2006.02.009

P. Lowe and C. Temple, Calcitonin and Insulin in Isobutylcyanoacrylate Nanocapsules: Protection Against Proteases and Effect on Intestinal Absorption in Rats, Journal of Pharmacy and Pharmacology, vol.29, issue.7, pp.547-552, 1994.
DOI : 10.1136/gut.29.8.1064

C. Lu, Y. Zu, and V. Yam, Nonionic surfactant-capped gold nanoparticles as postcolumn reagents for high-performance liquid chromatography assay of low-molecular-mass biothiols, Journal of Chromatography A, vol.1163, issue.1-2, pp.328-332, 2007.
DOI : 10.1016/j.chroma.2007.07.045

R. Lu, P. Kopeckova, and J. Kopecek, Degradation and aggregation of human calcitonin in vitro, Pharmaceutical Research, vol.16, issue.3, pp.359-367, 1999.
DOI : 10.1023/A:1018813416523

W. Lu and T. Park, Protein release from poly(lactic-co-glycolic acid) microspheres: protein stability problems, J Pharm Sci Technol, vol.49, pp.13-19, 1995.

A. Lucke, J. Kiermaier, and A. Gopferich, Peptide acylation by poly(?-hydroxy esters), Pharmaceutical Research, vol.19, issue.2, pp.175-181, 2002.
DOI : 10.1023/A:1014272816454

G. Lyritis and G. Trovas, Analgesic effects of calcitonin, Bone, vol.30, issue.5, pp.71-74, 2002.
DOI : 10.1016/S8756-3282(02)00714-7

D. Malkov, R. Angelo, H. Wang, E. Flanders, H. Tang et al., Oral Delivery of Insulin with the eligen(&#174;) Technology: Mechanistic Studies, Current Drug Delivery, vol.2, issue.2, pp.191-197, 2005.
DOI : 10.2174/1567201053586001

D. Manica, J. Lapos, A. Jones, and A. Ewing, Analysis of the stability of amino acids derivatized with naphthalene-2,3-dicarboxaldehyde using high-performance liquid chromatography and mass spectrometry, Analytical Biochemistry, vol.322, issue.1, pp.68-78, 2003.
DOI : 10.1016/j.ab.2003.07.002

D. Manicourt, J. Devogelaer, M. Azria, and S. Silverman, Rationale for the potential use of calcitonin in osteoarthritis, J Musculoskelet Neuronal Interact, vol.5, pp.285-293, 2005.

E. Martenka, Praca magisterska: Nanocz?stki i ich zastosowanie do wprowadzania sond fluorogennych do komórek drody, 2004.

T. Matsuyama, T. Morita, Y. Horikiri, H. Yamahara, and H. Yoshino, Improved nasal absorption of salmon calcitonin by powdery formulation with N-acetyl-l-cysteine as a mucolytic agent, Journal of Controlled Release, vol.115, issue.2, pp.183-188, 2006.
DOI : 10.1016/j.jconrel.2006.08.004

I. Medintz, H. Mattoussi, and A. Clapp, Potential clinical applications of quantum dots, Int J Nanomed, vol.3, pp.151-167, 2008.

R. Mehta, R. Jeyanthi, S. Calis, B. Thanoo, K. Burton et al., Biodegradable microspheres as depot system for patenteral delivery of peptide drugs, Journal of Controlled Release, vol.29, issue.3, pp.375-384, 1994.
DOI : 10.1016/0168-3659(94)90082-5

L. Michelet, M. Zaffagnini, and V. Massot, Thioredoxins, glutaredoxins, and glutathionylation: new crosstalks to explore, Photosynthesis Research, vol.279, issue.112, pp.225-245, 2006.
DOI : 10.1016/S0167-4838(99)00119-3

J. Mieyal, M. Gallogly, S. Qanungo, E. Sabens, and M. Shelton, -Glutathionylation, Antioxidants & Redox Signaling, vol.10, issue.11, pp.1941-1988, 2008.
DOI : 10.1089/ars.2008.2089

D. Moriarty, S. Vagts, and D. Raleigh, A Role for the C-Terminus of Calcitonin in Aggregation and Gel Formation: A Comparative Study of C-Terminal Fragments of Human and Salmon Calcitonin, Biochemical and Biophysical Research Communications, vol.245, issue.2, pp.344-348, 1998.
DOI : 10.1006/bbrc.1998.8425

K. Morimoto, H. Katsumata, T. Yabuta, K. Iwanaga, M. Kakemi et al., Evaluation of gelatin microspheres for nasal and intramuscular administrations of salmon calcitonin, European Journal of Pharmaceutical Sciences, vol.13, issue.2, pp.179-185, 2001.
DOI : 10.1016/S0928-0987(01)00094-X

M. Muller, B. Zechmann, and G. Zellnig, Ultrastructural localization of glutathione in Cucurbita pepo plants, Protoplasma, vol.223, pp.213-219, 2004.

R. Mundargi, V. Babu, V. Rangaswamy, P. Patel, and T. Aminabhavi, Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives, Journal of Controlled Release, vol.125, issue.3, pp.193-209, 2008.
DOI : 10.1016/j.jconrel.2007.09.013

D. Na, Y. Youn, S. Lee, M. Son, W. Kim et al., Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectrometry, Journal of Controlled Release, vol.92, issue.3, pp.291-299, 2003.
DOI : 10.1016/S0168-3659(03)00366-3

D. Na, Y. Youn, and E. Park, Stability of PEGylated salmon calcitonin in nasal mucosa, Journal of Pharmaceutical Sciences, vol.93, issue.2, pp.256-261, 2004.
DOI : 10.1002/jps.10537

O. Orwar, H. Fishman, N. Ziv, R. Scheller, and R. Zare, Use of 2,3-Naphthalenedicarboxaldehyde Derivatization for Single-Cell Analysis of Glutathione by Capillary Electrophoresis and Histochemical Localization by Fluorescence Microscopy, Analytical Chemistry, vol.67, issue.23, pp.4261-4268, 1995.
DOI : 10.1021/ac00119a010

H. Ostergaard, C. Tachibana, and J. Winther, Monitoring disulfide bond formation in the eukaryotic cytosol, The Journal of Cell Biology, vol.72, issue.3, pp.337-345, 2004.
DOI : 10.1006/abio.1995.1246

J. Panyam and V. Labhasetwar, Biodegradable nanoparticles for drug and gene delivery to cells and tissue, Advanced Drug Delivery Reviews, vol.55, issue.3, pp.329-347, 2003.
DOI : 10.1016/S0169-409X(02)00228-4

W. Parak, T. Pellegrino, and C. Plank, Labelling of cells with quantum dots, Nanotechnology, vol.16, issue.2, pp.9-25, 2005.
DOI : 10.1088/0957-4484/16/2/R01

C. Parmentier, M. Wellman, A. Nicolas, G. Siest, and P. Leroy, Simultaneous measurement of reactive oxygen species and reduced glutathione using capillary electrophoresis and laser-induced fluorescence detection in cultured cell lines, Electrophoresis, vol.627, issue.14, pp.2938-2944, 1999.
DOI : 10.1016/0378-4347(93)80078-I

R. Paroni, E. Vecchi, G. Cighetti, C. Arcelloni, I. Fermo et al., HPLC with o-phthalaldehyde precolumn derivatization to measure total, oxidized, and protein-bound glutathione in blood, plasma, and tissue, Clin Chem, vol.41, pp.448-454, 1995.

C. Pinto-reis, R. Neufeld, A. Ribeiro, and F. Veiga, Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles, Nanomedicine: Nanotechnology, Biology and Medicine, vol.2, issue.1, pp.8-21, 2006.
DOI : 10.1016/j.nano.2005.12.003

G. Plosker and D. Mctavish, Intranasal Salcatonin (Salmon Calcitonin), Drugs & Aging, vol.8, issue.5, pp.378-400, 1996.
DOI : 10.2165/00002512-199608050-00006

S. Prabhu, L. Tran, and G. Betageri, Biodegradable Polymer Implants, Drug Delivery, vol.1, issue.6, pp.393-398, 2005.
DOI : 10.1002/(ISSN)1097-4636

C. Prego, M. Fabre, D. Torres, and M. Alonso, Efficacy and Mechanism of Action of Chitosan Nanocapsules for Oral Peptide Delivery, Pharmaceutical Research, vol.25, issue.3, pp.549-556, 2006.
DOI : 10.1111/j.2042-7158.1990.tb07033.x

J. Prousky, The treatment of pulmonary diseases and respiratory-related conditions with inhaled (nebulized or aerosolized) glutathione. Evid Based, Complement Alternat Med, vol.5, pp.27-35, 2008.

B. Purdue, N. Tilakaratne, and P. Sexton, Molecular Pharmacology of the Calcitonin Receptor, Receptors and Channels, vol.8, pp.243-255, 2002.
DOI : 10.1080/10606820213681

J. Qin, N. Ye, and L. Yu, Simultaneous and ultrarapid determination of reactive oxygen species and reduced glutathione in apoptotic leukemia cells by microchip electrophoresis, ELECTROPHORESIS, vol.93, issue.6, pp.1155-1162, 2005.
DOI : 10.1002/elps.200410136

I. Rahman, A. Kode, and S. Biswas, Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method, Nature Protocols, vol.63, issue.6, pp.3159-3165, 2006.
DOI : 10.1164/ajrccm.159.1.9803109

G. Rammouz, M. Lacroix, J. Garrigues, V. Poinsot, and F. Couderc, The use of naphthalene-2,3-dicarboxaldehyde for the analysis of primary amines using high-performance liquid chromatography and capillary electrophoresis, Biomedical Chromatography, vol.67, issue.12, pp.1223-1239, 2007.
DOI : 10.1097/01.ALC.0000131979.78003.34

J. Reginster, Treatment of Bone in Elderly Subjects: Calcium, Vitamin D, Fluor, Bisphosphonates, Calcitonin, Hormone Research, vol.43, issue.1-3, pp.83-88, 1995.
DOI : 10.1159/000184243

U. Resch-genger, M. Grabolle, S. Cavaliere-jaricot, R. Nitschke, and T. Nann, Quantum dots versus organic dyes as fluorescent labels, Nature Methods, vol.13, issue.9, pp.763-775, 2008.
DOI : 10.1177/002215540305101214

URL : https://hal.archives-ouvertes.fr/hal-00798911

J. Riegler and T. Nann, Application of luminescent nanocrystals as labels for biological molecules, Analytical and Bioanalytical Chemistry, vol.379, issue.7-8, pp.913-919, 2004.
DOI : 10.1007/s00216-004-2706-y

N. Rouhier, S. Lemaire, and J. Jacquot, The Role of Glutathione in Photosynthetic Organisms: Emerging Functions for Glutaredoxins and Glutathionylation, Annual Review of Plant Biology, vol.59, issue.1, pp.143-166, 2008.
DOI : 10.1146/annurev.arplant.59.032607.092811

S. Saby, P. Leroy, and J. Block, Escherichia coli resistance to chlorine and glutathione synthesis in response to oxygenation and starvation, Appl Environ Microbiol, vol.65, pp.5600-5603, 1999.

S. Sahoo, J. Panyam, S. Prabha, and V. Labhasetwar, Residual polyvinyl alcohol associated with poly (d,l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake, Journal of Controlled Release, vol.82, issue.1, pp.105-114, 2002.
DOI : 10.1016/S0168-3659(02)00127-X

S. Santra, J. Xu, K. Wang, and W. Tan, Luminescent Nanoparticle Probes for Bioimaging, Journal of Nanoscience and Nanotechnology, vol.4, issue.6, pp.590-598, 2004.
DOI : 10.1166/jnn.2004.017

C. Schultz, Fluorescent Revelations, Chemistry & Biology, vol.16, issue.2, pp.107-111, 2009.
DOI : 10.1016/j.chembiol.2009.02.001

M. Schwarzlander, M. Fricker, and C. Muller, Confocal imaging of glutathione redox potential in living plant cells, Journal of Microscopy, vol.8, issue.2, pp.299-316, 2008.
DOI : 10.1111/j.1365-2818.2008.02030.x

R. Shah and M. Khan, Protection of salmon calcitonin breakdown with serine proteases by various ovomucoid species for oral drug delivery, Journal of Pharmaceutical Sciences, vol.93, issue.2, pp.392-406, 2004.
DOI : 10.1002/jps.10557

R. Shah and M. Khan, Regional permeability of salmon calcitonin in isolated rat gastrointestinal tracts: Transport mechanism using Caco-2 cell monolayer, The AAPS Journal, vol.6, issue.4, pp.1-5, 2004.
DOI : 10.1208/aapsj060431

R. Shah, A. Siddiqui, G. Shah, and M. Khan, A validated HPLC assay for simultaneous analysis of salmon calcitonin and duck ovomucoid, Pharmazie, vol.58, pp.620-622, 2003.

P. Sharma, S. Brown, G. Walter, S. Santra, and B. Moudgil, Nanoparticles for bioimaging, Advances in Colloid and Interface Science, vol.123, issue.126, pp.471-485, 2006.
DOI : 10.1016/j.cis.2006.05.026

D. Sheehan, G. Meade, V. Foley, and C. Dowd, Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily, Biochemical Journal, vol.360, issue.1, pp.1-16, 2001.
DOI : 10.1042/bj3600001

W. Shen, Oral peptide and protein delivery: unfulfilled promises?, Drug Discovery Today, vol.8, issue.14, pp.607-608, 2003.
DOI : 10.1016/S1359-6446(03)02692-8

K. Shimada and K. Mitamura, Derivatization of thiol-containing compounds, Journal of Chromatography B: Biomedical Sciences and Applications, vol.659, issue.1-2, pp.227-241, 1994.
DOI : 10.1016/0378-4347(93)E0444-U

H. Sies, Glutathione and its role in cellular functions, Free Radical Biology and Medicine, vol.27, issue.9-10, pp.916-921, 1999.
DOI : 10.1016/S0891-5849(99)00177-X

J. Sigurjonsdottir, T. Loftsson, and M. Masson, Influence of cyclodextrins on the stability of the peptide salmon calcitonin in aqueous solution, International Journal of Pharmaceutics, vol.186, issue.2, pp.205-213, 1999.
DOI : 10.1016/S0378-5173(99)00183-0

S. Silverman, Nasal calcitonin, Endocrine, vol.47, issue.2, pp.199-202, 1997.
DOI : 10.1164/ajrccm/142.1.104

S. Silverman, Calcitonin, Endocrinology and Metabolism Clinics of North America, vol.32, issue.1, pp.273-284, 2003.
DOI : 10.1016/S0889-8529(02)00060-9

S. Silverman and M. Azria, The Analgesic Role of Calcitonin Following Osteoporotic Fracture, Osteoporosis International, vol.13, issue.11, pp.858-867, 2002.
DOI : 10.1007/s001980200118

M. Simoes, M. Pereira, and M. Vieira, Validation of respirometry as a short-term method to assess the efficacy of biocides, Biofouling, vol.68, issue.1, pp.9-17, 2005.
DOI : 10.1046/j.1365-2672.1999.00791.x

C. Simons, S. Walsh, J. Maillard, and A. Russell, A NOTE: Ortho-Phthalaldehyde: proposed mechanism of action of a new antimicrobial agent, Letters in Applied Microbiology, vol.13, issue.4, pp.299-302, 2000.
DOI : 10.1046/j.1365-2672.1999.00913.x

P. Sinko, C. Smith, L. Mcwhorter, W. Stern, E. Wagner et al., Utility of Pharmacodynamic Measures for Assessing the Oral Bioavailability of Peptides. 1. Administration of Recombinant Salmon Calcitonin in Rats, Journal of Pharmaceutical Sciences, vol.84, issue.11, pp.1374-1378, 1995.
DOI : 10.1002/jps.2600841120

G. Smirnova and O. Oktyabrsky, Glutathione in Bacteria, Biochemistry (Moscow), vol.186, issue.11, pp.1199-1211, 2005.
DOI : 10.1016/S1383-5718(99)00187-4

K. Soppimath, T. Aminabhavi, A. Kulkarni, and W. Rudzinski, Biodegradable polymeric nanoparticles as drug delivery devices, Journal of Controlled Release, vol.70, issue.1-2, pp.1-20, 2001.
DOI : 10.1016/S0168-3659(00)00339-4

C. Stevenson and M. Tan, Solution stability of salmon calcitonin at high concentration for delivery in an implantable system, Journal of Peptide Research, vol.41, issue.2, pp.129-139, 2000.
DOI : 10.1007/BF02556814

L. Stratton, A. Dong, M. Manning, and J. Carpenter, Drug Delivery Matrix Containing Native Protein Precipitates Suspended in a Poloxamer Gel, Journal of Pharmaceutical Sciences, vol.86, issue.9, pp.1006-1010, 1997.
DOI : 10.1021/js970034d

H. Takeuchi, Y. Matsui, H. Yamamoto, and Y. Kawashima, Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats, Journal of Controlled Release, vol.86, issue.2-3, pp.235-242, 2003.
DOI : 10.1016/S0168-3659(02)00411-X

T. Takizawa and J. Robinson, FluoroNanogold Is a Bifunctional Immunoprobe for Correlative Fluorescence and Electron Microscopy, Journal of Histochemistry & Cytochemistry, vol.44, issue.4, pp.481-485, 2000.
DOI : 10.1083/jcb.100.4.1157

L. Tanko, Y. Bagger, and P. Alexandersen, Safety and Efficacy of a Novel Salmon Calcitonin (sCT) Technology-Based Oral Formulation in Healthy Postmenopausal Women: Acute and 3-Month Effects on Biomarkers of Bone Turnover, Journal of Bone and Mineral Research, vol.81, issue.9, pp.1531-1538, 2004.
DOI : 10.1248/bpb.23.946

C. Tasset, N. Barette, S. Thysman, J. Ketelslegers, D. Lemoine et al., Polyisobutylcyanoacrylate nanoparticles as sustained release system for calcitonin, Journal of Controlled Release, vol.33, issue.1, pp.23-30, 1995.
DOI : 10.1016/0168-3659(94)00060-8

J. Tauskela, K. Hewitt, and L. Kang, Evaluation of glutathione-sensitive fluorescent dyes in cortical culture, Glia, vol.55, issue.4, pp.329-341, 2000.
DOI : 10.1002/(SICI)1098-1136(200006)30:4<329::AID-GLIA20>3.0.CO;2-R

N. Thirawong, J. Thongborisute, H. Takeuchi, and P. Sriamornsak, Improved intestinal absorption of calcitonin by mucoadhesive delivery of novel pectin???liposome nanocomplexes, Journal of Controlled Release, vol.125, issue.3, pp.236-245, 2008.
DOI : 10.1016/j.jconrel.2007.10.023

D. Townsend, K. Tew, and H. Tapiero, The importance of glutathione in human disease, Biomedicine & Pharmacotherapy, vol.57, issue.3-4, pp.145-155, 2003.
DOI : 10.1016/S0753-3322(03)00043-X

A. Trapani, V. Laquintana, and N. Denora, Eudragit RS 100 microparticles containing 2-hydroxypropyl-??-cyclodextrin and glutathione: Physicochemical characterization, drug release and transport studies, European Journal of Pharmaceutical Sciences, vol.30, issue.1, pp.64-74, 2007.
DOI : 10.1016/j.ejps.2006.10.003

J. Treumer and G. Valet, Flow-cytometric determination of glutathione alterations in vital cells by o-phthaldialdehyde (OPT) staining, Experimental Cell Research, vol.163, issue.2, pp.518-524, 1986.
DOI : 10.1016/0014-4827(86)90082-0

T. Tsai, R. Mehta, and P. Deluca, Adsorption of peptides to poly(D,L-lactide-co-glycolide): 2. Effect of solution properties on the adsorption, International Journal of Pharmaceutics, vol.127, issue.1, pp.43-52, 1996.
DOI : 10.1016/0378-5173(95)04112-5

W. Tseng, K. Lee, and H. Chang, Using Nile Red-Adsorbed Gold Nanoparticles To Locate Glutathione within Erythrocytes, Langmuir, vol.21, issue.23, pp.10676-10683, 2005.
DOI : 10.1021/la0511034

G. Ublacker, J. Johnson, F. Siegel, and R. Mulcahy, Influence of glutathione Stransferases on cellular glutathione determination by flow cytometry using monochlorobimane, Cancer Res, vol.51, pp.1783-1788, 1991.

J. Vasir, M. Reddy, and V. Labhasetwar, Nanosystems in Drug Targeting: Opportunities and Challenges, Current Nanoscience, vol.1, issue.1, pp.47-64, 2005.
DOI : 10.2174/1573413052953110

A. Vila, A. Sanchez, M. Tob?o, P. Calvo, and M. Alonso, Design of biodegradable particles for protein delivery, Journal of Controlled Release, vol.78, issue.1-3, pp.15-24, 2002.
DOI : 10.1016/S0168-3659(01)00486-2

S. Wallach, J. Farley, D. Baylink, and L. Brenner-gati, Effects of calcitonin on bone quality and osteoblastic function, Calcified Tissue International, vol.130, issue.suppl 1, pp.335-339, 1993.
DOI : 10.1016/0169-6009(92)92027-N

F. Wang, W. Tan, Y. Zhang, X. Fan, and M. Wang, Luminescent nanomaterials for biological labelling, Nanotechnology, vol.17, issue.1, pp.1-13, 2006.
DOI : 10.1088/0957-4484/17/1/R01

J. Wang, D. Chow, H. Heiati, and W. Shen, Reversible lipidization for the oral delivery of salmon calcitonin, Journal of Controlled Release, vol.88, issue.3, pp.369-380, 2003.
DOI : 10.1016/S0168-3659(03)00008-7

L. Wang, L. Wang, T. Xia, G. Bian, L. Dong et al., A highly sensitive assay for spectrofluorimetric determination of reduced glutathione using organic nano-probes, Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, vol.61, issue.11-12, 2005.
DOI : 10.1016/j.saa.2004.07.041

W. Wang, Instability, stabilization, and formulation of liquid protein pharmaceuticals, International Journal of Pharmaceutics, vol.185, issue.2, pp.129-188, 1999.
DOI : 10.1016/S0378-5173(99)00152-0

M. Weert, W. Hennink, and W. Jiskoot, Protein instability in poly(lactic-co-glycolic acid) microparticles, Pharmaceutical Research, vol.17, issue.10, pp.1159-1167, 2000.
DOI : 10.1023/A:1026498209874

V. Windisch, F. Deluccia, L. Duhau, F. Herman, J. Mencel et al., Degradation Pathways of Salmon Calcitonin in Aqueous Solution, Journal of Pharmaceutical Sciences, vol.86, issue.3, pp.359-364, 1997.
DOI : 10.1021/js9602305

C. Winterbourn, Superoxide as an intracellular radical sink, Free Radical Biology and Medicine, vol.14, issue.1, pp.85-90, 1993.
DOI : 10.1016/0891-5849(93)90512-S

A. Witschi, S. Reddy, B. Stofer, and B. Lauterburg, The systemic availability of oral glutathione, European Journal of Clinical Pharmacology, vol.120, issue.6, pp.667-669, 1992.
DOI : 10.1164/ajrccm/139.2.370

G. Wu, Y. Fang, S. Yang, J. Lupton, and N. Turner, Glutathione Metabolism and Its Implications for Health, The Journal of Nutrition, vol.552, issue.3, pp.489-492, 2004.
DOI : 10.1113/jphysiol.2003.049478

H. Yamamoto, Y. Kuno, S. Sugimoto, H. Takeuchi, and Y. Kawashima, Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions, Journal of Controlled Release, vol.102, issue.2, pp.373-381, 2005.
DOI : 10.1016/j.jconrel.2004.10.010

H. Yoo and T. Park, Biodegradable nanoparticles containing protein-fatty acid complexes for oral delivery of salmon calcitonin, J Pharm Sci, vol.93, pp.488-495, 2004.

B. Youan, A. Hussain, and N. Nguyen, Evaluation of sucrose esters as alternative surfactants in microencapsulation of proteins by the solvent evaporation method, AAPS PharmSci, vol.5, issue.2, p.22, 2003.
DOI : 10.1208/ps050222

Y. Youn, J. Jung, S. Oh, S. Yoo, and K. Lee, Improved intestinal delivery of salmon calcitonin by Lys18-amine specific PEGylation: Stability, permeability, pharmacokinetic behavior and in vivo hypocalcemic efficacy, Journal of Controlled Release, vol.114, issue.3, pp.334-342, 2006.
DOI : 10.1016/j.jconrel.2006.06.007

Y. Youn, M. Kwon, D. Na, S. Chae, S. Lee et al., Improved intrapulmonary delivery of site-specific PEGylated salmon calcitonin: Optimization by PEG size selection, Journal of Controlled Release, vol.125, issue.1, pp.68-75, 2008.
DOI : 10.1016/j.jconrel.2007.10.008

W. Yu, E. Chang, R. Drezek, and V. Colvin, Water-soluble quantum dots for biomedical applications, Biochemical and Biophysical Research Communications, vol.348, issue.3, pp.781-786, 2006.
DOI : 10.1016/j.bbrc.2006.07.160

M. Zaidi, A. Inzerillo, B. Moonga, P. Bevis, and C. Huang, Forty years of calcitonin???where are we now? A tribute to the work of Iain Macintyre, FRS, Bone, vol.30, issue.5, pp.655-663, 2002.
DOI : 10.1016/S8756-3282(02)00688-9

B. Zechmann, G. Zellnig, and M. Muller, Changes in the Subcellular Distribution of Glutathione during Virus Infection in Cucurbita pepo (L.), Plant Biology, vol.60, issue.1, pp.49-57, 2005.
DOI : 10.1007/s00705-003-0005-0

B. Zechmann, M. Muller, and G. Zellnig, Intracellular adaptations of glutathione content in Cucurbita pepo L. induced by treatment with reduced glutathione and buthionine sulfoximine, Protoplasma, vol.212, issue.2-4, pp.197-209, 2006.
DOI : 10.1007/0-306-47644-4_2

B. Zechmann, F. Mauch, L. Sticher, and M. Muller, Subcellular immunocytochemical analysis detects the highest concentrations of glutathione in mitochondria and not in plastids, Journal of Experimental Botany, vol.152, issue.14, 2008.
DOI : 10.1007/s00705-006-0880-2

B. Zolnik and D. Burgess, Effect of acidic pH on PLGA microsphere degradation and release, Journal of Controlled Release, vol.122, issue.3, pp.338-344, 2007.
DOI : 10.1016/j.jconrel.2007.05.034